- Preparation of indole sulfonamides as modulators of progesterone receptors, World Intellectual Property Organization, , ,
Cas no 945557-04-0 (5-Bromo-3-chloropyridine-2-carbonitrile)
5-Bromo-3-chloropyridine-2-carbonitrile Chemical and Physical Properties
Names and Identifiers
-
- 5-Bromo-3-chloropicolinonitrile
- 5-bromo-3-chloropyridine-2-carbonitrile
- 5-bromo-3-chloro- 2-Pyridinecarbonitrile
- C6H2BrClN2
- 5-bromo-2-cyano-3-chloropyridine
- 5-Bromo-3-chloro-2-cyanopyridine
- AK126247
- 3-CHLORO-2-CYANO-5-BROMOPYRIDINE
- PubChem21378
- SIYPZKHSXDFDRA-UHFFFAOYSA-N
- STL556444
- BBL102641
- SBB065634
- EBD583205
- SB13037
- OR17892
- FCH1327419
- 5-bromo-3-chloro-2-pyridinecarbonitrile
- SY1017
- 5-Bromo-3-chloro-2-pyridinecarbonitrile (ACI)
- PS-3988
- 2-Pyridinecarbonitrile,5-bromo-3-chloro-
- 945557-04-0
- MFCD12827550
- SCHEMBL1630093
- DTXSID70670193
- SY101718
- AU-004/43502035
- AKOS005257802
- J-517016
- DB-079954
- 5-Bromo-3-chloropyridine-2-carbonitrile
-
- MDL: MFCD12827550
- Inchi: 1S/C6H2BrClN2/c7-4-1-5(8)6(2-9)10-3-4/h1,3H
- InChI Key: SIYPZKHSXDFDRA-UHFFFAOYSA-N
- SMILES: N#CC1C(Cl)=CC(Br)=CN=1
Computed Properties
- Exact Mass: 215.90900
- Monoisotopic Mass: 215.909
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 0
- Hydrogen Bond Acceptor Count: 2
- Heavy Atom Count: 10
- Rotatable Bond Count: 0
- Complexity: 164
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- Topological Polar Surface Area: 36.7
- XLogP3: 2.2
Experimental Properties
- Density: 1.85
- Boiling Point: 289°C at 760 mmHg
- Flash Point: 128.6°C
- Refractive Index: 1.628
- PSA: 36.68000
- LogP: 2.36918
5-Bromo-3-chloropyridine-2-carbonitrile Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| Fluorochem | 047006-250mg |
5-Bromo-3-chloro-2-cyanopyridine |
945557-04-0 | 95% | 250mg |
£14.00 | 2022-03-01 | |
| Fluorochem | 047006-1g |
5-Bromo-3-chloro-2-cyanopyridine |
945557-04-0 | 95% | 1g |
£34.00 | 2022-03-01 | |
| Fluorochem | 047006-5g |
5-Bromo-3-chloro-2-cyanopyridine |
945557-04-0 | 95% | 5g |
£119.00 | 2022-03-01 | |
| Fluorochem | 047006-10g |
5-Bromo-3-chloro-2-cyanopyridine |
945557-04-0 | 95% | 10g |
£196.00 | 2022-03-01 | |
| Alichem | A029157830-250mg |
5-Bromo-3-chloropyridine-2-carbonitrile |
945557-04-0 | 98% | 250mg |
$680.00 | 2023-08-31 | |
| Alichem | A029157830-500mg |
5-Bromo-3-chloropyridine-2-carbonitrile |
945557-04-0 | 98% | 500mg |
$980.00 | 2023-08-31 | |
| Alichem | A029157830-1g |
5-Bromo-3-chloropyridine-2-carbonitrile |
945557-04-0 | 98% | 1g |
$1685.00 | 2023-08-31 | |
| TRC | B684413-100mg |
5-Bromo-3-chloropyridine-2-carbonitrile |
945557-04-0 | 100mg |
$ 64.00 | 2023-04-18 | ||
| TRC | B684413-250mg |
5-Bromo-3-chloropyridine-2-carbonitrile |
945557-04-0 | 250mg |
$ 75.00 | 2023-04-18 | ||
| TRC | B684413-500mg |
5-Bromo-3-chloropyridine-2-carbonitrile |
945557-04-0 | 500mg |
$ 87.00 | 2023-04-18 |
5-Bromo-3-chloropyridine-2-carbonitrile Production Method
Production Method 1
1.2 Reagents: Copper ; 30 min, reflux
1.3 Reagents: Sodium hydroxide Solvents: Water ; basified, cooled
Production Method 2
1.2 Reagents: Copper ; 1 h, reflux; cooled
1.3 Reagents: Water ; cooled
1.4 Reagents: Sodium hydroxide Solvents: Water ; basified
- Preparation of pyrazole- and imidazole-carboxamide derivatives as modulators of androgen receptor, World Intellectual Property Organization, , ,
5-Bromo-3-chloropyridine-2-carbonitrile Raw materials
5-Bromo-3-chloropyridine-2-carbonitrile Preparation Products
5-Bromo-3-chloropyridine-2-carbonitrile Related Literature
-
Eric Besson,Stéphane Gastaldi,Emily Bloch,Selma Aslan,Hakim Karoui,Olivier Ouari,Micael Hardy Analyst, 2019,144, 4194-4203
-
Gaurav J. Shah,Eric P.-Y. Chiou,Ming C. Wu,Chang-Jin “CJ” Kim Lab Chip, 2009,9, 1732-1739
-
Liao Xiaoqing,Li Ruiyi,Li Zaijun,Sun Xiulan,Wang Zhouping,Liu Junkang New J. Chem., 2015,39, 5240-5248
-
Yukiya Kitayama Polym. Chem., 2014,5, 2784-2792
Additional information on 5-Bromo-3-chloropyridine-2-carbonitrile
Market Research and Analysis of 5-Bromo-3-chloropyridine-2-carbonitrile in the Chemical-Biomedical Field
The compound 5-Bromo-3-chloropyridine-2-carbonitrile, identified by the CAS registry number 945557-04-0, has emerged as a significant molecule in the chemical-biomedical industry. This compound has garnered attention due to its potential applications in drug discovery, particularly in the development of novel therapeutic agents targeting various diseases, including cancer and infectious disorders.
Recent studies have highlighted the role of 5-Bromo-3-chloropyridine-2-carbonitrile as a promising lead compound in medicinal chemistry. Its unique structural features, including the bromine and chlorine substituents on the pyridine ring, contribute to its high reactivity and selectivity in biochemical reactions. These properties make it an ideal candidate for use in combinatorial chemistry and high-throughput screening processes.
Market demand for this compound has been driven by its increasing use in preclinical research and early-stage drug development. Major pharmaceutical companies and academic research institutions are actively exploring its potential as a building block for complex molecular architectures. Additionally, the compound's versatility in synthetic organic chemistry has expanded its utility across multiple therapeutic areas.
Global suppliers of 5-Bromo-3-chloropyridine-2-carbonitrile are strategically positioned to meet the growing demand from both industrial and academic sectors. Key players in this market are focusing on optimizing production processes to ensure high-quality standards while maintaining competitive pricing. The availability of this compound through various chemical suppliers has facilitated its widespread adoption in research laboratories worldwide.
In conclusion, 5-Bromo-3-chloropyridine-2-carbonitrile (CAS No. 945557-04-0) represents a valuable asset in the chemical-biomedical landscape. Its role as a versatile building block in drug discovery underscores its importance to both industry and academia. As research continues to uncover new applications for this compound, its market presence is expected to grow further, driven by advancements in synthetic methodologies and therapeutic innovations.
945557-04-0 (5-Bromo-3-chloropyridine-2-carbonitrile) Related Products
- 85331-33-5(3,5-dichloropyridine-2-carbonitrile)
- 1807027-63-9(4-Bromo-3-chloropicolinonitrile)
- 760207-83-8(3-bromo-5-chloro-pyridine-2-carbonitrile)
- 1211581-78-0((5-Bromo-3-chloropyridin-2-yl)methanamine)
- 2460501-07-7(5-bromo-3-chloro-2-(methyl-d3)pyridine-4,6-d2)
- 205751-22-0(Pyridinecarbonitrile, chloro-)
- 38180-46-0(3-chloropyridine-2-carbonitrile)
- 1416714-02-7((5-Bromo-3-chloropyridin-2-yl)methanamine hydrochloride)
- 894074-81-8(3-Chloro-6-methylpicolinonitrile)
- 914358-72-8(5-Bromo-3-chloro-2-methylpyridine)